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New & Noteworthy 32 
We examined whether the respiratory muscles of humans contribute to systemic oxidative 33 
stress following inspiratory flow resistive breathing, if the amount of oxidative stress is 34 
influenced by the level of resistive load, and whether the amount of oxidative stress is related 35 
to the degree of diaphragm fatigue incurred. Only when sufficiently strenuous, inspiratory 36 
flow resistive breathing elevates plasma F2-isoprostanes, and our novel data show this is not 37 




























We questioned whether the respiratory muscles of humans contribute to systemic oxidative 63 
stress following inspiratory flow resistive breathing, if the amount of oxidative stress is 64 
influenced by the level of resistive load, and whether the amount of oxidative stress is related 65 
to the degree of diaphragm fatigue incurred. Eight young and healthy participants attended 66 
the laboratory for 4 visits on separate days. During the first visit, height, body mass, lung 67 
function and maximal inspiratory mouth and transdiaphragmatic pressure (Pdimax) were 68 
assessed. During visits 2-4, participants undertook inspiratory flow resistive breathing with 69 
either no resistance (Control) or resistive loads equivalent to 50 and 70% of their Pdimax 70 
(Pdimax50% and Pdimax70%) for 30 min. Participants undertook 1 resistive load per visit, and 71 
the order that they undertook the loads was randomized. Inspiratory muscle pressures were 72 
higher (P < 0.05) during the 5th and final min of Pdimax50% and Pdimax70% compared to 73 
Control. Plasma F2-isoprostanes increased (P < 0.05) following inspiratory flow resistive 74 
breathing at Pdimax70%. There were no increases in plasma protein carbonyls and total 75 
antioxidant capacity. Further, although we evidenced small reductions in transdiapragmaic 76 
twitch pressures (PdiTW) after inspiratory flow resistive breathing at Pdimax50% and Pdimax70%, 77 
this was not related to the increase in plasma F2-isoprostanes. Our novel data suggest that 78 
only when sufficiently strenuous, inspiratory flow resistive breathing in humans elicits 79 
systemic oxidative stress evidenced by elevated plasma F2-isoprostanes, and based on our 80 









Increased respiratory muscle work is encountered during strenuous whole body exercise, 87 
asthma attacks, exacerbations of chronic obstructive pulmonary disease, and during periods 88 
of imposed flow resistive breathing (22, 40, 49). Inspiratory flow resistive breathing requires 89 
inspiration against a variable diameter orifice that results in increased diaphragm and 90 
accessory muscle force production to overcome the resistive load imposed.  91 
 92 
Reactive oxygen species (ROS) form as products under normal physiological conditions due 93 
to the partial reduction of molecular oxygen (42, 43). Oxidative stress is defined as 94 
macromolecular oxidative damage along with a disturbance of redox signaling and control 95 
and usually results from either excessive ROS production, mitochondrial dysfunction, 96 
impaired antioxidant system, or a combination of these factors (42, 43). ROS produced under 97 
oxidative stress can damage all cellular biomolecules including lipids, proteins, carbohydrates 98 
and DNA (42, 43). The measurement of oxidative stress in vivo is difficult as ROS are highly 99 
reactive and/or have a very short half-life (<1 s for some), so they can be estimated from 100 
changes in free radicals, radical mediated damages to lipids, proteins and nucleic acids, and 101 
antioxidant enzyme activity or concentration (39). Therefore, a battery of different markers 102 
that are reliable are essential to summarize the effects of oxidative stress (39). Systemic 103 
measurements can include protein carbonyls as a marker of protein oxidation, total 104 
antioxidant capacity for exogenous antioxidant utilization, and F2-isoprostanes for lipid 105 
peroxidation, which is widely regarded as a gold standard because of their chemical stability 106 
and prevalence in all human tissues and biological fluids (35, 38, 64).  107 
 108 
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Oxidative stress is elevated in the diaphragms of animals exposed to inspiratory flow resistive 109 
breathing, and the amount of oxidative stress is positively associated with the level of 110 
resistive load (1, 7, 12, 13, 51). Supplementation with a combination of antioxidants also 111 
reduces the response of plasma cytokines in humans following 45 min of inspiratory flow 112 
resistive breathing undertaken at 75% of maximal inspiratory mouth pressure (PImax) (57). 113 
Mild and acute exposure to exogenous ROS generally increases the muscles ability to 114 
generate force (11, 24, 61), whereas stronger or prolonged exposure as occurs during flow 115 
resistive breathing (1, 7, 12, 13, 51), significantly reduces respiratory muscle force generation 116 
(19, 45). Indeed, in vitro studies have shown that ROS released from diaphragm fibers 117 
promotes low-frequency diaphragm fatigue (5, 25, 46, 52), which in humans can be measured 118 
objectively using phrenic nerve stimulation (29). Supplementation with the antioxidant N-119 
acetylcysteine before inspiratory resistive breathing or heavy exercise may also attenuate 120 
respiratory muscle fatigue (21, 56). In patients with severe chronic obstructive pulmonary 121 
disease, diaphragm fatigue can contribute to muscle dysfunction (6, 17), and the development 122 
of respiratory failure (41). Taken together, these animal, in vitro and supplementation studies 123 
indicate that resistive breathing leads to increased oxidative stress, that the amount of 124 
oxidative stress is associated with the level of resistive load, and that this is related to 125 
diaphragm fatigue. The findings for the animal and in vitro studies, however, have not been 126 
repeated in humans.  127 
 128 
Accordingly, we questioned whether the respiratory muscles of humans contribute to 129 
systemic oxidative stress following inspiratory flow resistive breathing, if the amount of 130 
oxidative stress is influenced by the level of resistive load, and whether the amount of 131 
oxidative stress is related to the degree of diaphragm fatigue incurred. We utilized a battery 132 
of oxidative stress markers including plasma F2-isoprostanes, protein carbonyls and total 133 
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antioxidant capacity and objectively measured low-frequency diaphragm fatigue using 134 
phrenic nerve stimulation. We hypothesized that oxidative stress would be increased 135 
following exposure to inspiratory flow resistive breathing, and greater with increased 136 
resistive loads, and the increase in oxidative stress measures would be related to the degree of 137 





















Participants  156 
Five males and three females that were free from respiratory disorders, and who provided 157 
written, informed consent participated in the study (Table 1). A self-reporting medical 158 
questionnaire confirmed that participants were free from illness and injury and not taking any 159 
medication and/or antioxidant supplements during the study. Each participant completed a 24 160 
h diet record prior to their first trial, which was then replicated prior to all subsequent trials. 161 
Participants reported that they were recreationally active, which included playing sports, and 162 
participating in aerobic and resistance exercise 3-4 days per week. Throughout the study, 163 
participants were instructed to adhere to their habitual exercise-training regimens and to not 164 
increase or decrease their volume of exercise. They were also instructed to not engage in any 165 
strenuous exercise the day preceding and the day of a trial. Participants arrived at the 166 
laboratory 4 h postprandially, having abstained from alcohol and caffeine in the 24 h before 167 
testing. All study procedures were approved by the University of Southern Queensland 168 
Research Ethics Committee, which adheres to the Declaration of Helsinki.  169 
[TABLE 1]  170 
 171 
 172 
Experimental design  173 
Participants attended the laboratory for 4 visits on separate days. Each laboratory visit was 174 
separated by a minimum of 48 h and took place at the same time of day. During the first visit, 175 
height, body mass, lung function, PImax and maximum transdiaphragmatic pressure (Pdimax) 176 
were assessed according to published guidelines and statements (4, 32). Subsequently, 177 
participants were familiarized with all other measurements and inspiratory flow resistive 178 
breathing. During visits 2-4, participants undertook inspiratory flow resistive breathing with 179 
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either no resistive load (Control), or loads equivalent to 50 and 70% of their Pdimax (Pdimax50% 180 
and Pdimax70%) for 30 min. These reflected “low”, “moderate” and “heavy” flow resistive 181 
loads, respectively. Participants undertook 1 resistive load per visit, and the order that they 182 
undertook the loads was randomized. Participants were naïve to the prescribed resistive load 183 
and the resistive loading device was hidden from view. The resistive loads were chosen 184 
because, through our pilot studies and other work (3, 8, 23), they were sustainable for 30 min 185 
and would elicit varying degrees of diaphragm fatigue. Transdiaphragmatic twitch pressures 186 
(PdiTW) were measured at Baseline, at 5 min, at the End, and +30 min after the completion of 187 
inspiratory flow resistive breathing trials. Blood samples for oxidative stress measures, 188 
respiratory pressures, cardiorespiratory data, and rating of perceived dyspnea (RPD; Borg 189 
modified CR10 scale (9) as a measure of the effort required to overcome the resistance) were 190 
measured at rest, during the 5th min, in the Final min, and +30 min after the completion of 191 
inspiratory flow resistive breathing trials.  192 
 193 
Pulmonary function and maximal inspiratory mouth and transdiaphragmatic pressure 194 
Pulmonary function was assessed using a calibrated testing system (JAEGER® Vyntus; 195 
CareFusion, San Diego, CA). PImax and Pdimax were assessed using the same experimental 196 
equipment used for the inspiratory flow resistive breathing. Participants inspired through a 197 
two-way non-rebreathing valve (Model 2730; Hans Rudolph, Shawnee Mission, KS) with 198 
resistance provided by a custom-built variable sized aperture with a length of 2 mm placed 199 
into the inspiratory port. To assess PImax and Pdimax, the aperture was closed and incorporated 200 
a 1 mm orifice to prevent glottic closure during inspiratory efforts. Mouth pressure was 201 
measured using a calibrated transducer (MLT844; AD Instruments, Dunedin, New Zealand) 202 
inserted into the mouth port of the two-way non-rebreathing valve. Inspiratory maneuvers for 203 
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PImax and Pdimax were performed while seated, initiated from residual volume, and sustained 204 
for at least 1 s. Repeat efforts separated by 30 s were performed until three serial measures 205 
differed by no more than 10% or 10 cmH2O, whichever was smallest (33). The highest value 206 
recorded was used for subsequent analysis.  207 
 208 
Respiratory muscle pressures  209 
Respiratory muscle pressures were quantified by measuring esophageal (Pe) and gastric (Pg) 210 
pressures using two 10 cm balloon-tipped latex catheters (Model 47-9005; Ackrad 211 
Laboratories, Cranford, NJ) which were attached to calibrated differential pressure 212 
transducers (MLT844; AD Instruments, Dunedin, New Zealand) (33, 34). The esophageal 213 
and gastric balloons were filled with 1 ml and 2 ml of air, respectively. During the first 214 
experimental trial, the distance from the tip of the nares to the most distal point of the 215 
catheters was recorded and replicated in subsequent trials. Pdi was calculated automatically 216 
using LabChart Pro software (AD Instruments, Bella Vista, Australia) by subtracting Pe from 217 
Pg. To estimate respiratory muscle energy expenditure (16), Pdi and Pe were integrated over 218 
the period of inspiratory flow and multiplied by breathing frequency and labeled the 219 
diaphragm pressure-time product (PTPdi) and the inspiratory muscle pressure-time product 220 
(PTPe), respectively. Nonphysiological flows and pressures that resulted from swallowing, 221 
coughing, and breath holding were visually identified and removed. Raw pressure data were 222 
recorded continuously at 200 Hz using a 16-channel analog-to-digital data acquisition system 223 




Respiratory muscle induced systemic oxidative stress 
10 
 
Cervical magnetic phrenic nerve stimulation 228 
Cervical magnetic phrenic nerve stimulation was applied via a double 70 mm coil connected 229 
to a Magstim 2002 stimulator (Magstim, Dyfed, UK). Participants initially rested for 20 min 230 
to minimize postactivation potentiation. Subsequently, while participants were sat upright and 231 
the neck flexed, the coil was placed over the midline between the 5th (C5) and 7th (C7) 232 
cervical vertebrae (50). The optimal coil position was defined as the vertebral level that when 233 
stimulated at 50% of maximum stimulator output evoked the highest PdiTW. This location was 234 
marked with indelible ink and used for subsequent stimulations. During stimulations, 235 
participants wore a noseclip, and prior to stimulation were instructed to hold breathing effort 236 
at functional residual capacity, which was inferred from visual feedback of Pe. To determine 237 
supramaximal phrenic nerve stimulation, three single twitches were obtained every 30 s at 238 
intensities of 50, 60, 70, 80, 85, 90, 95, and 100% of maximal stimulator output. A plateau in 239 
PdiTW responses with increasing stimulation intensities indicated maximum depolarization of 240 
the phrenic nerves.  241 
 242 
Maximum PdiTW was assessed at each measurement point every 30 s using three stimuli at 243 
100% of maximal stimulator output. Additionally, PdiTW at each measurement point was 244 
followed by the assessment of the potentiated PdiTW response. Participants performed a 3 s 245 
maximal Müeller maneuver and ~5 s later a single stimuli was delivered. This procedure was 246 
repeated six times with each measure separated by 30 s. The average of the three individual 247 
non-potentiated PdiTW responses and the final three potentiated PdiTW responses were used for 248 
analysis. This procedure was undertaken at Baseline, after 5 min of inspiratory flow resistive 249 
breathing, at the End, and +30 min after the completion of inspiratory flow resistive breathing 250 
trials. 251 
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Inspiratory flow resistive breathing   252 
Following cervical magnetic phrenic nerve stimulation, participants remained seated and 253 
continued to wear a nose clip. Resting measurements were collected for 5 min whilst 254 
participants breathed through a mouthpiece to a two-way non-rebreathing valve. For 255 
Pdimax50% and Pdimax70% trials, the custom-built variable sized aperture was adjusted to 256 
narrow its diameter. This was continued until participants could match the target Pdi which 257 
was displayed on a screen in front of them and monitored continuously to ensure adequate 258 
pressure development. Participants were asked to maintain tidal volumes close to those 259 
achieved at rest, and the proportion of Pdi contributed by Pg and Pe was not controlled. In the 260 
event that the partial pressure of end-tidal carbon dioxide fell from resting concentrations, 261 
carbon dioxide was added to the inspirate to maintain isocapnia and avoid the deleterious 262 
effects of hypocapnia (e.g., light-headedness, confusion, paresthesia, tetany). This occurred in 263 
two participants after ~3 min during the Pdimax70% trial when end-tidal carbon dioxide partial 264 
pressure fell below 30 mmHg. Once isocapnia was restored, these participants were coached 265 
to maintain expired volumes close to that achieved at rest to prevent further episodes of 266 
hypocapnia. Participants maintained a breathing frequency of 15 breaths·min-1 and a duty 267 
cycle of 0.5 by listening to a computer-generated audio signal with distinct inspiratory and 268 
expiratory tones.  269 
 270 
Cardiorespiratory responses 271 
Standard ventilatory responses were measured on a breath-by-breath basis using a metabolic 272 
cart (JAEGER® Vyntus; CareFusion, San Diego, CA) with the flow sensor inserted into the 273 
mouth port of the two-way non-rebreathing valve. Cardiac frequency and estimated arterial 274 
oxygen saturation were measured using a monitor (Polar T34; Polar Electro, Kempele, 275 
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Finland) and fingertip pulse oximeter (Radical-7 Pulse CO-Oximeter, Masimo Corporation, 276 
Irvine, CA), respectively.  277 
 278 
Blood sampling  279 
Ten mL of venous blood was sampled at each time point from an antecubital vein via an 280 
indwelling 21-G cannula. Blood was transferred into precooled tubes containing K3E EDTA 281 
(BD vacutainers; Franklin Lakes, NJ). Samples were stored on ice before being centrifuged at 282 
2500 rpm for 10 min at 4°C. Plasma was then aliquoted and stored at -80°C until biochemical 283 
assays were performed. 284 
 285 
Plasma F2-isoprostanes 286 
Samples were analyzed in duplicate using an optimized method for quantification of total F2-287 
isoprostanes using gas chromatography–tandem mass spectrometry (10). Isoprostanes were 288 
extracted from plasma after saponification with methanolic NaOH. Samples were spiked with 289 
8-iso-PGF2α-d4 (Cayman Chemicals, Ann Arbor, MI) as an internal standard and incubated 290 
at 42°C for 60 min. Samples were then acidified to pH 3 with hydrochloric acid, and hexane 291 
was added and samples were mixed for 10 min before centrifugation. The supernatant was 292 
removed, and the remaining solution extracted with ethyl acetate and dried under nitrogen. 293 
Samples were reconstituted with acetonitrile, transferred into vials with silanized glass inserts 294 
and dried. Derivatization with pentafluorobenzylbromide and diisopropylethylamine and 295 
incubation at room temperature for 30 min followed. Samples were then dried under nitrogen 296 
before pyridine, bis(trimethylsilyl)trifluoroacetamide 99% and trimethylchlorosilane 1% were 297 
added and incubated at 45°C for 20 min. Finally, hexane was added and samples were mixed, 298 
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then 1 ml was injected for analysis using gas chromatography mass spectrometry (Varian; 299 
Belrose, Australia) in negative chemical ionization mode. The laboratory coefficient of 300 
variation for this assay is 4.5%. 301 
 302 
Plasma protein carbonyls 303 
Protein carbonyls were analyzed using an adapted version of the methodology from Levine et 304 
al. (27). Duplicate plasma samples were incubated with 2,4 dinitrophenylhydrazine in 2.5M 305 
hydrochloric acid (HCl) for 1 h in the dark. Plasma blanks were incubated in 2.5M HCl only. 306 
All samples were then precipitated with 20% trichloroacetic acid (TCA) on ice and 307 
centrifuged at 10 000 g for 10 min. Supernatants were discarded, and the pellets resuspended 308 
in 10% TCA and again centrifuged as above. Supernatants were removed, and the pellets 309 
resuspended in 1:1 ethanol: ethylacetate solution. After centrifugation as above, the pellets 310 
were washed twice more with the ethanol:ethylacetate solution. Pellets were then 311 
resuspended in 6M guanidine hydrochloride solution and 220 mL of samples and blanks were 312 
transferred to microplate wells and absorbance read at 370 nm with correction at 650 nm 313 
using a microplate reader (Fluostar Optima; BMG Labtech, Offenburg, Germany). Protein 314 
carbonyls concentration was normalized to plasma protein content measured using a Pierce 315 
BCA protein assay kit (Thermo Scientific, Victoria, Australia). The laboratory coefficient of 316 
variation for this assay is 11.9%. 317 
 318 
Plasma total antioxidant capacity 319 
Total antioxidant capacity was measured using a modified version (36) of an assay previously 320 
described (47, 62), and adapted for a Cobas Mira autoanalyser (Cobas Mira, Roche 321 
Diagnostica, Switzerland). Briefly, plasma was incubated with metmyoglobin and 2,20-322 
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azino-bis(3-ethylbenzothiazoline-6-sulphonic acid). After incubation, hydrogen peroxide was 323 
added, and the sample was incubated again. Absorbance was measured 324 
spectrophotometrically to determine total antioxidant capacity. The laboratory coefficient of 325 
variation for this assay is 1.9%. 326 
 327 
Statistical analysis 328 
Statistical analyses were performed using SPSS for Windows (IBM, Chicago, IL). An initial 329 
power calculation was performed on the basis of previous work (36) showing that 8 330 
participants would be required to demonstrate a 10% increase in plasma F2-isoprostanes with 331 
an alpha of 0.05 and power 0.8. All data was confirmed as parametric via a Shapiro-Wilk test 332 
for normality. The data from supramaximal phrenic nerve stimulation was analyzed using a 333 
one-way ANOVA. The data from the three inspiratory flow resistive breathing trials were 334 
analyzed using a two way repeated measures ANOVA procedure to determine the effects of 335 
‘time’ (Rest/Baseline, 5th min, Final min/End and +30 min) and ‘resistive load’ (Control, 336 
Pdimax50% and Pdimax70%). Following significant time x resistive load interaction effects, 337 
planned pairwise comparisons were made using the Bonferroni method. Pearson’s product 338 
moment correlation coefficient was used to examine the relationship between the degree of 339 
oxidative stress incurred and (I) flow resistive load; and (II) degree of diaphragm fatigue 340 
incurred. Reliability was assessed using a coefficient of variation calculated from a pooled 341 
mean of all trials. Statistical significance was set at P < 0.05. Results are presented as means 342 








Cardiorespiratory and perceptual responses  348 
Inspiratory muscle pressures and estimates of respiratory muscle energy expenditure during 349 
inspiratory flow resistive breathing are shown in Table 2 and Figure 1, respectively. PTPdi, 350 
PTPe, PIpeak, Pepeak and Pdipeak were higher during the 5th and final min of Pdimax50% and 351 
Pdimax70% compared to Control. The relative contribution of the diaphragm to the inspiratory 352 
muscle pressure-time product (PTPdi/PTPe) was lower during the 5th min of Pdimax50% 353 
compared to Control (Figure 1). RPD was elevated during the 5th and final min of Pdimax70% 354 
compared to both Pdimax50% and Control (Table 2). Duty cycle was increased during the 5th 355 
and final min of Pdimax70% and 5th min of Pdimax50% compared to Control. There was a time 356 
x resistive load interaction effect (P = 0.003) for cardiac frequency (Table 2), but no pairwise 357 
differences. There were no differences between Control, Pdimax50% and Pdimax70% for minute 358 
ventilation, breathing frequency, tidal volume, estimated arterial oxygen saturation and end 359 
tidal carbon dioxide pressure (Table 2). 360 
 361 
Markers of oxidative stress  362 
Markers of oxidative stress during inspiratory flow resistive breathing are shown in Figure 3. 363 
Plasma F2-isoprostanes were higher during the final min and at +30 min of inspiratory flow 364 
resistive breathing at Pdimax70% compared to Control and Pdimax50% (Figure 2). There was a 365 
main effect of time (P = 0.048) for total antioxidant capacity, but no main effect of resistive 366 
load. There were no differences between Control, Pdimax50% and Pdimax70% for plasma 367 
protein carbonyls and total antioxidant capacity.  368 
[TABLE 2] [FIGURE 1] [FIGURE 2]  369 
 370 
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Transdiaphragmatic twitch pressures   371 
A plateau (i.e., no significant increase in amplitude with increasing stimulation intensity) in 372 
PdiTW amplitude (Figure 3) was observed in response to supramaximal cervical magnetic 373 
phrenic nerve stimulation, indicating maximal depolarization of the phrenic nerves. The 374 
within and between coefficient of variation for PdiTW and potentiated PdiTW at rest was <5%. 375 
Absolute (P = 0.03) and relative potentiated PdiTW decreased (P = 0.02) following inspiratory 376 
flow resistive breathing at Pdimax50% and Pdimax70%. Compared to Baseline, Pdimax50% and 377 
Pdimax70% were reduced at the End and at +30 min after inspiratpry flow resistive breathing 378 
(Figure 4). There were no main effects of resistive load or time x resistive load interactions 379 
(Figure 4). 380 
[FIGURE 3] [FIGURE 4]  381 
Time Course and relationship between markers of oxidative stress and diaphragm fatigue  382 
Although the time course of the increase in plasma F2-isoprostanes during inspiratory flow 383 
resistive breathing at Pdimax70% corresponded with the decrease PdiTW (Figure 5), there were 384 
no significant relationships between the individual percentage change from Rest for plasma 385 
F2-isoprostanes and percentage change from Baseline for potentiated PdiTW after Pdimax70% 386 
(Figure 6).   387 












Main findings 397 
The aim of this study was to examine whether the respiratory muscles of humans contribute 398 
to systemic oxidative stress following inspiratory flow resistive breathing, if the amount of 399 
oxidative stress is influenced by the level of resistive load, and whether the amount of 400 
oxidative stress is related to the degree of diaphragm fatigue incurred. The main finding was 401 
that the only measured marker of oxidative stress to increase was plasma F2-isoprostanes 402 
following inspiratory flow resistive breathing at Pdimax70%. There were no increases in 403 
plasma protein carbonyls and total antioxidant capacity. Further, although we evidenced 404 
small reductions in PdiTW after inspiratory flow resistive breathing at Pdimax50% and 405 
Pdimax70%, this was not related to the increase in plasma F2-isoprostanes.     406 
 407 
Markers of oxidative stress  408 
We observed an increase in plasma F2-isoprostanes following inspiratory flow resistive 409 
breathing at Pdimax70%, but not at Pdimax50%. We chose to measure F2-isoprostanes in blood, 410 
and because of their chemical stability and prevalence in all human tissues and biological 411 
fluids, this measurement is widely regarded as gold standard for the assessment of oxidative 412 
stress (35, 38, 64). F2-isoprostanes represent a marker of lipid peroxidation and acute exercise 413 
and muscle contractions generally increase concentrations in skeletal muscle and plasma (37). 414 
Further, F2-isoprostanes are elevated in the diaphragms of rats exposed to prolonged periods 415 
of inspiratory flow resistive breathing (51). Thus, we infer that the increase in plasma F2-416 
isoprostanes that we observed following inspiratory flow resistive breathing at Pdimax70% are 417 
released from the contracting respiratory muscles into the systemic circulation. In contrary to 418 
our hypothesis, we did not see an elevation of plasma F2-isoprostanes following inspiratory 419 
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flow resistive breathing at Pdimax50%. This may be due to the intensity of the loading that was 420 
insufficient to observe increased appearance rates of ROS to exceed the ability of 421 
antioxidants to counteract their effects. Indeed, it has been previously reported that F2-422 
isoprostane concentrations are higher following high-intensity intermittent rather than 423 
constant load cycling exercise (14).  424 
  425 
We did not observe an increase in plasma protein carbonyl concentration and total 426 
antioxidant capacity. Plasma protein carbonyl concentrations are a marker of protein 427 
oxidation. They are elevated in the diaphragms of rats when they are exposed to inspiratory 428 
flow resistive breathing, and concentrations are higher after 8 and 12 days, compared to 4 429 
days (51). However, certain exercise conditions can result in a net decrease in plasma protein 430 
carbonyl concentrations, which occurs in parallel with increases in other biomarkers of 431 
oxidative stress. Greater inspiratory flow resistive intensities and/or durations may be 432 
required to elicit increases in markers of oxidative stress. Exercise intensity (>70% maximal 433 
oxygen uptake) and prolonged duration (>60 min) appear to be the main contributing factors 434 
in the observed post-exercise increases in plasma protein carbonyl concentration (59). 435 
However, it must be noted that whole body exercise engages a significantly greater muscle 436 
mass than inspiratory flow resistive breathing. The factors influencing decreases in protein 437 
carbonyls are more difficult to interpret, but likely involve the clearance of oxidized proteins 438 
from plasma, potentially by plasma proteasomes, excretion, or uptake into active tissues (59).  439 
 440 
Total antioxidant capacity is a marker of exogenous antioxidant utilization (30). Other studies 441 
using maximal treadmill exercise have also found no changes to plasma total antioxidant 442 
capacity immediately post exercise (2, 15). However, others have observed significant 443 
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increases at 30 min (58) and 1 h (60). The timing of measurements may therefore be 444 
important for total antioxidant capacity, and plasma protein carbonyl measurements. For 445 
example, around 50 min of exercise resulted in a 32% increase in protein carbonyls 30 min 446 
post-exercise and 94% 4 h later (31). Our experimental design unfortunately did not allow us 447 
to take measurements beyond 30 min after inspiratory flow resistive breathing as we wanted 448 
to mirror the time course of the reduction in PdiTW. We acknowledge that this is a limitation of 449 
our study design, and future research would aim to undertake blood sampling at later time 450 
points. We must also note that whole body exercise engages a significantly greater muscle 451 
mass than inspiratory flow resistive breathing. 452 
 453 
Diaphragm fatigue and relationship between markers of oxidative stress 454 
Similar to others (19), we observed a reduction in potentiated and non-potentiated PdiTW 455 
following inspiratory resistive breathing which is indicative of low-frequency peripheral 456 
fatigue. The underlying mechanisms are thought to be reduced Ca2
+ release from the 457 
sarcoplasmic reticulum, reduced Ca2
+ sensitivity of the myofibrils, and/or damaged 458 
sarcomeres caused by overextension of the muscle fiber (20). Mild and acute exposure to 459 
exogenous ROS generally increases the muscles ability to generate force (11, 24, 61), 460 
whereas stronger or prolonged exposure as occurs during flow resistive breathing (1, 7, 12, 461 
13, 51), significantly reduces respiratory muscle force generation (19, 45). Indeed, in vitro 462 
studies have shown that ROS released from diaphragm fibers promotes low-frequency 463 
diaphragm fatigue (5, 25, 26, 46, 52). Supplementation with the antioxidant N-acetylcysteine 464 
before inspiratory resistive breathing or heavy exercise may also attenuate respiratory muscle 465 
fatigue (21, 56). Therefore, we hypothesized that the amount of oxidative stress that we 466 
observed would be related to the degree of diaphragm fatigue incurred. However, although 467 
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the time course of the increase in plasma F2-isoprostanes during inspiratory flow resistive 468 
breathing at Pdimax70% corresponded with the decrease PdiTW, there were no significant 469 
relationships between the absolute and relative changes in potentiated and non-potentiated 470 
PdiTW. These indirect measures of lipid peroxidation and respiratory muscle force generation 471 
in our systemic in vivo experiment may not be strong enough to demonstrate significant 472 
relationships and warrant further experimentation. The source of the increase in plasma F2-473 
isoprostanes could also be the lung, as previous research had demonstrated that inspiratory 474 
resistive breathing in animal models can lead to lung injury and oxidative stress (18, 53-55). 475 
This may also explain the lack of relationship between the increases in plasma F2-476 
isoprostanes and the reduction in PdiTW.   477 
 478 
Methodological limitations 479 
There are several methodological limitations to our study that need to be acknowledged. 480 
Firstly, sex differences occur in respiratory physiology (28, 48), and we acknowledge that our 481 
data may be confounded by including both male and female participants. Although in a small 482 
sample size, the individual responses presented in Figure 5 do not indicate that there are any 483 
sex differences, but this warrants further investigation. Secondly, we did not control the 484 
contributions of Pe to Pdi, which allowed participants to possibly preferentially use their rib 485 
cage muscles rather than the diaphragm and to alternate between these muscle groups. 486 
Thirdly, the outcome assessor was not blinded to the level of inspiratory resistance or other 487 
participant information as they undertook both the experimental testing and analyses. Finally, 488 
as our oxidative stress markers are indirect measurements they may have contributed to the 489 
lack of association with PdiTW.  490 
 491 




In conclusion, inspiratory flow resistive breathing undertaken at Pdimax70% induces 493 
significant increases in the gold standard oxidative stress biomarker, plasma F2-isoprostanes. 494 
However, there were no increases in plasma protein carbonyls and total antioxidant capacity 495 
and although we evidenced small reductions in PdiTW after inspiratory flow resistive breathing 496 
at Pdimax50% and Pdimax70%, this was not related to the increase in plasma F2-isoprostanes. 497 
Our novel data suggest that only when sufficiently strenuous, inspiratory flow resistive 498 
breathing in humans elicits systemic oxidative stress, and based on our data this is not related 499 
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FIGURES  716 
 717 
Figure 1. Diaphragm pressure-time product (PTPdi; A), inspiratory muscle pressure-time 718 
product (PTPe; B) and the relative contribution of diaphragm to the inspiratory muscle 719 
pressure-time product (PTPdi/PTPe; C) responses to inspiratory flow resistive breathing for 720 
Control and at 50 and 70% of peak transdiaphragmatic pressure (Pdimax50% and Pdimax70%). 721 
Values are mean ± SD. * Significantly different from Control (P < 0.05). † Significantly 722 
different from Pdimax50% (P < 0.05).   723 




Figure 2. Plasma total antioxidant capacity (A), protein carbonly (B) and F2-isoprostane (C) 725 
responses to inspiratory flow resistive breathing for Control and at 50 and 70% of peak 726 
transdiaphragmatic pressure (Pdimax50% and Pdimax70%). Values are mean ± SD. * 727 
Significantly different from Control (P < 0.05). † Significantly different from Pdimax50% (P < 728 
0.05).   729 
 730 
 731 




Figure 3. Individual and group mean transdiaphragmatic twitch pressure (PdiTW) in response 733 
to cervical magnetic stimulation of increasing stimulation intensity. 734 
 735 




Figure 4. Absolute (A) and relative (A) and potentiated transdiaphragmatic twitch pressure 737 
(PdiTW) responses to inspiratory flow resistive breathing for Control and at 50 and 70% of 738 
peak transdiaphragmatic pressure (Pdimax50% and Pdimax70%). Values are mean ± SD. * 739 

















Figure 5. Individual male (solid line) and female (dashed line) plasma F2-isoprostanes (A) 754 
and absolute potentiated transdiaphragmatic twitch pressure (PdiTW) (B) responses to 755 








Figure 6. Percentage change from Rest to Final min for plasma F2-isoprostanes vs. percentage 761 
change from Baseline to End during inspiratory flow resistive breathing at 70% of peak 762 































FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; PImax, maximal inspiratory 791 
mouth pressure; Pdimax, maximal transdiaphragmatic pressure. Predicted values for pulmonary 792 

















 Male (n = 5) Female (n = 3) 
Age, years 26 ± 5 26 ± 4 
Height, cm 176 ± 7 164 ± 9 
Body mass, kg 91 ± 8 70 ± 9 
FVC, L 5.01 ± 0.79 4.30 ± 0.94 
FVC, % predicted 101 ± 4 109 ± 17 
FEV1, L 4.11 ± 0.76 3.59 ± 0.73 
FEV1, % predicted 99 ± 12 106 ± 15 
FEV1/FVC, % 79.8 ± 7.0 80.7 ± 1.9 
FEV1/FVC, % predicted 96 ± 8 97 ± 3 
PImax, cmH2O 101 ± 35 117 ± 48 
PImax, % predicted 92 ± 22 131 ± 14 
Pdimax, cmH2O 90 ± 27 98 ± 24 




Table 2. Cardiorespiratory and perceptual responses to inspiratory flow resistive breathing for 811 
Control and at 50 and 70% of peak transdiaphragmatic pressure (Pdimax50% and Pdimax70%). 812 
Values are mean  SD. 813 
 814 
PIpeak, peak inspiratory mouth pressure; Pepeak, peak esophageal pressure; Pdipeak, peak 815 
transdiaphragmatic pressure; RPD, rating of perceived dyspnea; V̇E, minute ventilation; fB, 816 
breathing frequency; VT, tidal volume; TI/TTOT, duty cycle; fC, cardiac frequency; SpO2, 817 
estimated arterial oxygen saturation; PETCO2, end tidal carbon dioxide pressure. * 818 
Variable Resistive load Rest 5th min Final min +30 min 
PIpeak, cmH2O Control -1.2  0.2 -1.2  0.2 -1.2  0.2 -1.2  0.2 
 Pdimax50% -1.1  0.4 -24.7  14.1* -34.5  22.0* -1.1  0.4 
 Pdimax70% -1.3  0.3 -35.2  22.1* -42.1  25.7* -1.3  0.4 
Pepeak, cmH2O Control -10.0  2.0 -9.5  1.5 -9.3  1.3 -10.0  2.0 
 Pdimax50% -9.6  2.5 -28.9  12.2* -37.3  19.9* -9.8  3.5 
 Pdimax70% -9.4  2.4 -37.4  19.8* -42.6  20.2* -9.2  1.4 
Pdipeak, cmH2O Control 28.5  5.3 27.6  5.4 26.6  4.6 30.3  5.9 
 Pdimax50% 27.1  7.8 47.4  11.5* 48.5  11.4* 26.6  6.6 
 Pdimax70% 32.4  6.2 63.2  17.1* 60.2  11.6* 30.4  5.0  
RPD Control 0.0  0.0 0.0  0.0 0.0  0.0 0.0  0.0 
 Pdimax50% 0.0  0.0 1.8  1.3 2.8  1.4* 0.1  0.2 
 Pdimax70% 0.0  0.0 4.7  2.4*† 6.5  2.6*† 0.3  0.4* 
V̇E, L∙min-1 Control 9.0  1.6 11.0  7.3 9.9  4.0 9.3  2.5 
 Pdimax50% 10.2  2.8 10.8  2.9 11.8  4.2 9.8  2.4 
 Pdimax70% 8.6  2.2 11.1  3.9 9.6  1.6 9.8  2.7 
fB, breaths∙min
-1 Control 16  5 15  0 15  1 14  4 
 Pdimax50% 14  3 15  0 15  0 15  5 
 Pdimax70% 16  7 14  1 15  0 15  5 
VT, L Control 0.68  0.11 0.88  0.58 0.80  0.32 0.88  0.23 
 Pdimax50% 0.95  0.31 0.88  0.24 0.94  0.34 0.89  0.41 
 Pdimax70% 0.71  0.25 0.98  0.29 0.78  0.13 0.86  0.32 
TI/TTOT Control 0.44  0.04 0.45  0.04 0.44  0.04 0.44  0.04 
 Pdimax50% 0.43  0.04 0.52  0.06* 0.50  0.08 0.43  0.05 
 Pdimax70% 0.42  0.06 0.54  0.06* 0.55  0.07* 0.43  0.03 
fC, beats∙min
-1 Control 65  9 66  9 64  11 65  11 
 Pdimax50% 70  16 75  14 75  14 67  17 
 Pdimax70% 68  13 77  12 80  13 66  11 
SpO2, % Control 97.1  1.2 97.6  1.1 97.4  1.2 98.0  0.9 
 Pdimax50% 97.6  0.9 97.6  1.1 98.1  0.7 97.9  0.7 
 Pdimax70% 97.5  1.1 98.0  0.6 97.1  1.4 98.2  0.7 
PETCO2, mmHg Control 36.3  5.4 34.1  8.0 34.5  7.4 35.2  5.4 
 Pdimax50% 34.5  4.5 34.0  5.4 35.3  5.1 34.8  4.7 
 Pdimax70% 34.9  4.9 35.7  9.4 35.0  6.1 34.1  3.6 
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Significantly different from Control at the same time point (P < 0.05). † Significantly 819 
different from Pdimax50% at the same time point (P < 0.05).   820 
 821 
 822 
 823 
